Our industry-recognized Education team is committed to sharing program findings, best practices, insights, and trends from our educational programs across a range of therapeutic areas. These findings are regularly published in peer-reviewed journals, as well as presented at medical, patient, and industry conferences.
Heart disease remains a major cause of morbidity, hospitalizations, and mortality, particularly in women. Women experience a higher symptom burden than men, are more frequently misdiagnosed, and are underrepresented in clinical trials for health failure treatment. To address these gaps, PlatformQ Health and the American Society for Preventive Cardiology launched...
Early diagnosis and intervention is crucial for improving the quality of life of patients with Duchenne Muscular Dystrophy. However, emerging guidelines and therapeutic advances have brought about competency gaps in understanding mutation-specific treatments and more. To address these gaps, PlatformQ Health, Parent Project Muscular Dystrophy, and the National Organization of...
Biomarker testing and new therapies are reshaping care of certain types of cancer. Yet many clinicians report a lack of awareness about and experience with such options. To address these barriers, Large Urology Group Practice Association (LUGPA) and PlatformQ Health collaborated in the creation of two serial education programs for...
PlatformQ Health is pleased to announce the publication of a poster at the 2021 ASCO Annual Meeting. Incorporating HER2/HER3 Targeted Therapies Across Solid Tumors: Addressing the Impact of Digital Education on Clinician Practice Patterns shares insights from a multi-session CME activity, Getting to Know HER: An In-Depth Discussion on HER2/HER3-Targeted...
Rare cancers and rare blood disorders present challenges to clinicians related to diagnosis and management. To shorten the diagnostic journey and improve clinician index of suspicion and management of rare cancers, the first annual NORD Rare Cancers Summit was launched in 2020. Partnering with NORD on this initiative was critical...
The 2021 ASCO Annual Meeting showcases what is possible when the cancer care community comes together to advance cancer research, treatment, and patient care. The abstract, Patient and Provider Education on HER2-Positive Metastatic Breast Cancer: Defining Gaps in Clinician Practice, Patient Behaviors, Patient-Provider Alignment, and Clinical Knowledge highlights key findings...
The Alliance for Continuing Education in the Health Professionals hosted a Call for Submissions of high-quality outcome-based programs that effectively reported on the measured impact of educational initiatives that resulted in improvements in quality of patient care, behavior change, and/or HCP knowledge and competency. At the 2021 Virtual Alliance Industry...
The American Academy of Dermatology's Virtual Meeting Experience returns April 23rd-25th and PlatformQ Health is excited to be presenting the e-poster presentation, "Moving the Needle with Virtual Education: Impact of Chronic Idiopathic Urticarial Education on Patients and Health Care Providers." The accepted poster analyzes the outcomes from an educational initiative...
PlatformQ Health is excited to be presenting four scientific posters at the 2021 AAN Annual Meeting from April 17th-22nd. The virtual conference will include nearly 100 different expert-led courses, thousands of scientific abstracts, networking opportunities, an interactive virtual exhibit hall, access to industry resources and updates about recent scientific breakthroughs....
Today, on March 1, 2021, PlatformQ Health is proud to be presenting a poster at the Rare Disease Day at NIH 2021 Virtual Event, for the first time. Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and highlights the recent research collaborations...
November's issue coincides with annual meeting of the world's largest professional society in hematology PlatformQ Health Education is pleased to announce the publication of three of our outcomes-evaluation abstracts in conjunction with the upcoming 62nd American Society of Hematology (ASH) Annual Meeting and Exposition. The abstracts are published and available...
Partners present findings from an outcome-centric joint educational initiative that showcases the impact rare disease education can have on improving health outcome. PlatformQ Health’s partnership with the National Organization for Rare Disorders (NORD) and CureSMA cultivated a successful educational program that led to the poster presentation, “Educational Impact of Digital...